WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1997020934) TRANSFERRIN BINDING PROTEINS OF PASTEURELLA HAEMOLYTICA AND VACC INES CONTAINING SAME
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1997/020934    International Application No.:    PCT/CA1996/000791
Publication Date: 12.06.1997 International Filing Date: 29.11.1996
Chapter 2 Demand Filed:    26.06.1997    
IPC:
A61K 39/00 (2006.01), C07K 14/285 (2006.01)
Applicants: LO, Reggie, Y., C. [CA/CA]; (CA).
SCHRYVERS, Anthony, Bernard [CA/CA]; (CA).
POTTER, Andrew, Allan [CA/CA]; (CA)
Inventors: LO, Reggie, Y., C.; (CA).
SCHRYVERS, Anthony, Bernard; (CA).
POTTER, Andrew, Allan; (CA)
Agent: BERESKIN & PARR; 40th floor, 40 King Street West, Toronto, Ontario M5H 3Y2 (CA)
Priority Data:
60/008,569 01.12.1995 US
2,164,274 01.12.1995 CA
Title (EN) TRANSFERRIN BINDING PROTEINS OF PASTEURELLA HAEMOLYTICA AND VACC INES CONTAINING SAME
(FR) PROTEINES DE PASTEURELLA HAEMOLYTICA LIANT LA TRANSFERINE, ET VACCINS CONTENANT CES PROTEINES
Abstract: front page image
(EN)Transferrin binding proteins from $i(Pasteurella haemolytica) and nucleic acid molecules encoding the proteins are disclosed. Antibodies against the proteins are disclosed. The invention also relates to vaccines containing the proteins of the invention. The invention also provides methods for identifying substances which affect the binding of transferrin to the proteins and methods for screening for agonists or antagonists of the binding of the proteins and transferrin.
(FR)Cette invention concerne des protéines provenant de Pasteurella haemolytica et se liant à la transférine, ainsi que des molécules d'acide nucléique codant ces protéines. Cette invention concerne également des anticorps dirigés contre ces protéines, ainsi que des vaccins contenant les protéines décrites dans la présente invention. Cette invention concerne enfin des procédés d'identification de substances altérant la liaison de la transférine aux protéines, ainsi que des procédés de criblage d'agonistes ou d'antagonistes de la liaison entre les protéines et la transférine.
Designated States: AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DE, DK, EE, ES, FI, GB, GE, HU, IL, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, TJ, TM, TR, TT, UA, UG, US, UZ, VN.
African Regional Intellectual Property Organization (KE, LS, MW, SD, SZ, UG)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)